Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,459 Cr
up ₹112 Cr vs Oct 2025
- Stocks held
- 36
- unchanged
- Top 10 weight
- 58.4%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 18
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In November 2025 it disclosed 36 stocks worth ₹8,459 Cr, up ₹112 Cr from Oct 2025. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), Lupin Limited (7.6%), Divi's Laboratories Limited (6.9%); the ten largest together made up 58.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.2% of its equity. Cash and debt stood at 0.5%. Compared with Oct 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
80%
Top-10 weight is higher than 80% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in November 2025
Download CSVEvery line the fund disclosed, with the change against Oct 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.55%
- Δ weight
- up 0.87 pts
- Value
- ₹1,146 Cr
- Δ value
- up ₹88.2 Cr
- Status
- Added
- Weight
- 7.59%
- Δ weight
- up 0.34 pts
- Value
- ₹642 Cr
- Δ value
- up ₹36.6 Cr
- Status
- Added
- Weight
- 6.90%
- Δ weight
- down 1.18 pts
- Value
- ₹583 Cr
- Δ value
- down ₹90.4 Cr
- Status
- Trimmed
- Weight
- 6.33%
- Δ weight
- up 0.04 pts
- Value
- ₹535 Cr
- Δ value
- up ₹10.5 Cr
- Status
- Added
- Weight
- 5.83%
- Δ weight
- up 0.21 pts
- Value
- ₹493 Cr
- Δ value
- up ₹24 Cr
- Status
- Added
- Weight
- 5.63%
- Δ weight
- down 0.34 pts
- Value
- ₹476 Cr
- Δ value
- down ₹22.4 Cr
- Status
- Trimmed
- Weight
- 3.47%
- Δ weight
- up 0.15 pts
- Value
- ₹293 Cr
- Δ value
- up ₹16.7 Cr
- Status
- Added
- Weight
- 3.41%
- Δ weight
- down 0.01 pts
- Value
- ₹288 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 2.90%
- Δ weight
- up 0.07 pts
- Value
- ₹246 Cr
- Δ value
- up ₹9.2 Cr
- Status
- Added
- Weight
- 2.77%
- Δ weight
- down 0.09 pts
- Value
- ₹235 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 2.75%
- Δ weight
- down 0.30 pts
- Value
- ₹232 Cr
- Δ value
- down ₹22.4 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- down 0.14 pts
- Value
- ₹226 Cr
- Δ value
- down ₹8.6 Cr
- Status
- Trimmed
- Weight
- 2.57%
- Δ weight
- down 0.02 pts
- Value
- ₹218 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 2.47%
- Δ weight
- up 0.15 pts
- Value
- ₹209 Cr
- Δ value
- up ₹14.9 Cr
- Status
- Added
- Weight
- 2.44%
- Δ weight
- up 0.06 pts
- Value
- ₹207 Cr
- Δ value
- up ₹7.4 Cr
- Status
- Added
- Weight
- 2.20%
- Δ weight
- down 0.09 pts
- Value
- ₹186 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 2.18%
- Δ weight
- up 0.04 pts
- Value
- ₹184 Cr
- Δ value
- up ₹5.8 Cr
- Status
- Added
- Weight
- 2.12%
- Δ weight
- up 0.18 pts
- Value
- ₹180 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 2.09%
- Δ weight
- up 0.08 pts
- Value
- ₹177 Cr
- Δ value
- up ₹8.9 Cr
- Status
- Added
- Weight
- 2.02%
- Δ weight
- down 0.15 pts
- Value
- ₹171 Cr
- Δ value
- down ₹10.1 Cr
- Status
- Trimmed
- Weight
- 1.99%
- Δ weight
- down 0.12 pts
- Value
- ₹168 Cr
- Δ value
- down ₹7.5 Cr
- Status
- Trimmed
- Weight
- 1.93%
- Δ weight
- up 0.43 pts
- Value
- ₹163 Cr
- Δ value
- up ₹38.2 Cr
- Status
- Added
- Weight
- 1.87%
- Δ weight
- down 0.11 pts
- Value
- ₹158 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 1.35%
- Δ weight
- down 0.14 pts
- Value
- ₹114 Cr
- Δ value
- down ₹9.8 Cr
- Status
- Trimmed
- Weight
- 1.24%
- Δ weight
- up 0.49 pts
- Value
- ₹105 Cr
- Δ value
- up ₹42.7 Cr
- Status
- Added
- Weight
- 1.23%
- Δ weight
- down <0.01 pts
- Value
- ₹104 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 1.20%
- Δ weight
- down 0.15 pts
- Value
- ₹101 Cr
- Δ value
- down ₹11.5 Cr
- Status
- Trimmed
- Weight
- 1.19%
- Δ weight
- down 0.12 pts
- Value
- ₹101 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 1.18%
- Δ weight
- down 0.06 pts
- Value
- ₹99.6 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 0.98%
- Δ weight
- down 0.02 pts
- Value
- ₹83 Cr
- Δ value
- down ₹23 L
- Status
- Held
- Weight
- 0.79%
- Δ weight
- down 0.11 pts
- Value
- ₹67.2 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
- Weight
- 0.76%
- Δ weight
- down 0.07 pts
- Value
- ₹64.5 Cr
- Δ value
- down ₹5.3 Cr
- Status
- Trimmed
- Weight
- 0.67%
- Δ weight
- down 0.05 pts
- Value
- ₹56.5 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 0.56%
- Δ weight
- down 0.06 pts
- Value
- ₹47 Cr
- Δ value
- down ₹4.2 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.55%
- Δ weight
- up 0.21 pts
- Value
- ₹46.2 Cr
- Δ value
- up ₹18.2 Cr
- Status
- Added
- Weight
- 0.45%
- Δ weight
- up 0.02 pts
- Value
- ₹38.1 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 0.19%
- Δ weight
- down 0.01 pts
- Value
- ₹15.8 Cr
- Δ value
- down ₹29 L
- Status
- Trimmed
What changed, Oct 2025 to Nov 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹88.2 Cr (+0.87% pts)
- Emcure Pharmaceuticals Limitedup ₹42.7 Cr (+0.49% pts)
- IPCA Laboratories Limitedup ₹38.2 Cr (+0.43% pts)
- Lupin Limitedup ₹36.6 Cr (+0.34% pts)
- Dr. Reddy's Laboratories Limited ₹24 Cr (+0.21% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2025, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts) and Retailing (+0.2 pts), and fell most in Healthcare Services (−0.6 pts).
- Pharmaceuticals & Biotechnology74.7% → 75.2%+0.4 pts
- Retailing3.3% → 3.5%+0.2 pts
- Healthcare Services21.3% → 20.8%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2022 | Nov 2024 | May 2025 | Aug 2025 | Oct 2025 | Nov 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.5% | 76.7% | 75.8% | 75.5% | 74.7% | 75.2% |
| Healthcare Services | 19.5% | 19.3% | 19.4% | 20.2% | 21.3% | 20.8% |
| Retailing | 0.1% | 3.3% | 4.3% | 3.7% | 3.3% | 3.5% |
| Pharmaceuticals | 1.5% | 0.7% | 0.6% | 0.6% | 0.6% | 0.6% |
Allocation in Nov 2025change vs Oct 2025
- Pharmaceuticals & Biotechnology (25)75.2%▲ 0.4 pts
- Healthcare Services (9)20.8%▼ 0.6 pts
- Retailing (1)3.5%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2025
0.5%
▲ 0.2 pts vs Oct 2025
- Cash alone
- 0.5%
- cash and net receivables
- A year earlier
- 3.1%
- Nov 2024 · now ▼ 2.5 pts
- Last 12 months
- 0.3% – 1.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.